Detalhe da pesquisa
1.
Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study.
Ann Rheum Dis
; 81(6): 861-867, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35190385
2.
Immune checkpoint inhibitor-induced inflammatory arthritis: a novel clinical entity with striking similarities to seronegative rheumatoid arthritis.
Clin Rheumatol
; 39(12): 3631-3637, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32472463